<DOC>
	<DOC>NCT00141375</DOC>
	<brief_summary>To evaluate long-term safety and efficacy of pregabalin in the treatment of neuropathic pain after spinal cord injury.</brief_summary>
	<brief_title>To Evaluate Long-Term Safety and Efficacy of Pregabalin in the Treatment of Neuropathic Pain After Spinal Cord Injury.</brief_title>
	<detailed_description />
	<mesh_term>Spinal Cord Injuries</mesh_term>
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Pregabalin</mesh_term>
	<criteria>Must have met the inclusion criteria of the preceding doubleblind BID study in central pain following spinal cord injury. Must have received study medication under doubleblind conditions. Patients cannot participate if they experienced a serious adverse event during the previous doubleblind BID study which was determined to be related to the study medication.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2008</verification_date>
</DOC>